{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T13:56:15Z","timestamp":1781704575362,"version":"3.54.5"},"reference-count":27,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,6,30]],"date-time":"2025-06-30T00:00:00Z","timestamp":1751241600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical and Biophysical Research Communications"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/j.bbrc.2025.152009","type":"journal-article","created":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T11:36:08Z","timestamp":1747222568000},"page":"152009","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Gnetin C sensitizes darolutamide-resistant prostate cancer cells by targeting NAD+ and energy metabolism"],"prefix":"10.1016","volume":"770","author":[{"given":"Mina","family":"Kawai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-6332-7965","authenticated-orcid":false,"given":"Tomofumi","family":"Saka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-4206-9572","authenticated-orcid":false,"given":"Shinya","family":"Kawano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-4820-5779","authenticated-orcid":false,"given":"Yudai","family":"Kudo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teiko Komori","family":"Nomura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryo","family":"Honda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuta","family":"Yoshino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hirohito","family":"Kashiwagi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2757-3736","authenticated-orcid":false,"given":"Naohito","family":"Abe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masayoshi","family":"Oyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2696-0897","authenticated-orcid":false,"given":"Akira","family":"Ikari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0578-9672","authenticated-orcid":false,"given":"Satoshi","family":"Endo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbrc.2025.152009_bib1","doi-asserted-by":"crossref","first-page":"T179","DOI":"10.1530\/ERC-16-0422","article-title":"Androgen receptor signaling in castration-resistant prostate cancer: a lesson in persistence","volume":"23","author":"Coutinho","year":"2016","journal-title":"Endocr. Relat. Cancer"},{"key":"10.1016\/j.bbrc.2025.152009_bib2","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1093\/jb\/mvab025","article-title":"Targeting Nrf2-antioxidant signalling reverses acquired cabazitaxel resistance in prostate cancer cells","volume":"170","author":"Endo","year":"2021","journal-title":"J. Biochem."},{"key":"10.1016\/j.bbrc.2025.152009_bib3","doi-asserted-by":"crossref","DOI":"10.1016\/j.abb.2023.109519","article-title":"Artepillin C overcomes apalutamide resistance through blocking androgen signaling in prostate cancer cells","volume":"735","author":"Ota","year":"2023","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.bbrc.2025.152009_bib4","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1056\/NEJMoa1815671","article-title":"Darolutamide in nonmetastatic, castration-resistant prostate cancer","volume":"380","author":"Fizazi","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bbrc.2025.152009_bib5","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1080\/14656566.2017.1329820","article-title":"Darolutamide (ODM-201) for the treatment of prostate cancer","volume":"18","author":"Shore","year":"2017","journal-title":"Expet Opin. Pharmacother."},{"key":"10.1016\/j.bbrc.2025.152009_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.abb.2024.110135","article-title":"Docosahexaenoic acid enhances the treatment efficacy for castration-resistant prostate cancer by inhibiting autophagy through Atg4B inhibition","volume":"760","author":"Kudo","year":"2024","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.bbrc.2025.152009_bib7","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24097925","article-title":"The role of NAD+, SIRTs interactions in stimulating and counteracting carcinogenesis","volume":"24","author":"Podyacheva","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbrc.2025.152009_bib8","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1158\/1535-7163.MCT-24-0225","article-title":"Targeting NAD+ metabolism vulnerability in FH-Deficient hereditary leiomyomatosis and renal cell carcinoma with the novel NAMPT inhibitor OT-82","volume":"24","author":"Najera","year":"2025","journal-title":"Mol. Cancer Therapeut."},{"key":"10.1016\/j.bbrc.2025.152009_bib9","doi-asserted-by":"crossref","first-page":"3349","DOI":"10.1007\/s13197-017-2793-3","article-title":"Fractionation using adsorptive macroporous resin HPD-600 enhances antioxidant activity of Gnetum gnemon L. seed hard shell extract","volume":"54","author":"Saraswaty","year":"2017","journal-title":"J. Food Sci. Technol."},{"key":"10.1016\/j.bbrc.2025.152009_bib10","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1002\/ptr.5363","article-title":"Preclinical pharmacokinetics and pharmacodynamics and content analysis of gnetol in foodstuffs","volume":"29","author":"Remsberg","year":"2015","journal-title":"Phytother Res."},{"key":"10.1016\/j.bbrc.2025.152009_bib11","doi-asserted-by":"crossref","DOI":"10.3390\/nu15183888","article-title":"Protective effects of gnetin C from melinjo seed extract against high-fat diet-induced hepatic steatosis and liver fibrosis in NAFLD mice model","volume":"15","author":"Kabir","year":"2023","journal-title":"Nutrients"},{"key":"10.1016\/j.bbrc.2025.152009_bib12","doi-asserted-by":"crossref","first-page":"231","DOI":"10.2220\/biomedres.39.231","article-title":"Gnetin C suppresses double-stranded RNA-induced C-C motif chemokine ligand 2 (CCL2) and CCL5 production by inhibiting toll-like receptor 3 signaling pathway","volume":"39","author":"Yoshida","year":"2018","journal-title":"Biomed. Res."},{"key":"10.1016\/j.bbrc.2025.152009_bib13","doi-asserted-by":"crossref","DOI":"10.3390\/cancers16071344","article-title":"The therapeutic efficacy and mechanism of action of gnetin C, a natural compound from the melinjo plant, in a preclinical mouse model of advanced prostate cancer","volume":"16","author":"Campanelli","year":"2024","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.bbrc.2025.152009_bib14","doi-asserted-by":"crossref","first-page":"4878","DOI":"10.1021\/acs.jmedchem.1c02113","article-title":"Discovery and structure-based optimization of novel Atg4B inhibitors for the treatment of castration-resistant prostate cancer","volume":"65","author":"Kudo","year":"2022","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bbrc.2025.152009_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.abb.2023.109824","article-title":"Activation of the TGF-\u03b21\/EMT signaling pathway by claudin-1 overexpression reduces doxorubicin sensitivity in small cell lung cancer SBC-3 cells","volume":"751","author":"Nagaoka","year":"2024","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.bbrc.2025.152009_bib16","doi-asserted-by":"crossref","first-page":"622","DOI":"10.3389\/fonc.2018.00622","article-title":"NAD metabolism in cancer therapeutics","volume":"8","author":"Yaku","year":"2018","journal-title":"Front. Oncol."},{"key":"10.1016\/j.bbrc.2025.152009_bib17","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1038\/nrneph.2017.5","article-title":"Role of NAD(+) and mitochondrial sirtuins in cardiac and renal diseases","volume":"13","author":"Hershberger","year":"2017","journal-title":"Nat. Rev. Nephrol."},{"key":"10.1016\/j.bbrc.2025.152009_bib18","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.tcb.2014.04.002","article-title":"NAD+ and sirtuins in aging and disease","volume":"24","author":"Imai","year":"2014","journal-title":"Trends Cell Biol."},{"key":"10.1016\/j.bbrc.2025.152009_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2022.114143","article-title":"NMNAT2: an important metabolic enzyme affecting the disease progression","volume":"158","author":"Li","year":"2023","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.bbrc.2025.152009_bib20","first-page":"7436","article-title":"FK866, a highly specific noncompetitive inhibitor of nicotinamide phosphoribosyltransferase, represents a novel mechanism for induction of tumor cell apoptosis","volume":"63","author":"Hasmann","year":"2003","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbrc.2025.152009_bib21","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1007\/s00018-016-2451-3","article-title":"Mitochondrial dynamics as regulators of cancer biology","volume":"74","author":"Trotta","year":"2017","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.bbrc.2025.152009_bib22","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1002\/jcp.21984","article-title":"Hypoxic enlarged mitochondria protect cancer cells from apoptotic stimuli","volume":"222","author":"Chiche","year":"2010","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.bbrc.2025.152009_bib23","doi-asserted-by":"crossref","first-page":"4814","DOI":"10.1038\/onc.2012.494","article-title":"Mitochondrial dynamics regulates migration and invasion of breast cancer cells","volume":"32","author":"Zhao","year":"2013","journal-title":"Oncogene"},{"key":"10.1016\/j.bbrc.2025.152009_bib24","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/293893","article-title":"Mitochondrial fusion proteins and human diseases","volume":"2013","author":"Ranieri","year":"2013","journal-title":"Neurol. Res. Int."},{"key":"10.1016\/j.bbrc.2025.152009_bib25","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1038\/s41416-020-0778-x","article-title":"Mitochondrial division inhibitor (mdivi-1) decreases oxidative metabolism in cancer","volume":"122","author":"Dai","year":"2020","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.bbrc.2025.152009_bib26","article-title":"MFN2 suppresses cancer progression through inhibition of mTORC2\/Akt signaling","volume":"7","author":"Xu","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bbrc.2025.152009_bib27","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1016\/j.bbabio.2017.01.012","article-title":"Mitochondria and cancer chemoresistance","volume":"1858","author":"Guerra","year":"2017","journal-title":"Biochim. Biophys. Acta Bioenerg."}],"container-title":["Biochemical and Biophysical Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X25007235?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X25007235?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T13:12:50Z","timestamp":1781701970000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006291X25007235"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":27,"alternative-id":["S0006291X25007235"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrc.2025.152009","relation":{},"ISSN":["0006-291X"],"issn-type":[{"value":"0006-291X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Gnetin C sensitizes darolutamide-resistant prostate cancer cells by targeting NAD+ and energy metabolism","name":"articletitle","label":"Article Title"},{"value":"Biochemical and Biophysical Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbrc.2025.152009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"152009"}}